ArticleJournal of cancer research and clinical oncology2019

Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study.

Rui Pedro Marques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.